Hospira issues a voluntary global recall of multiple lots of ketorolac tromethamine injection | American Pharmacists Association Skip to main content

Advertisement

American Pharmacists Association American Pharmacists Association Connect Contact UsLogin/Register Join APhA Search form Search Advanced Search LEARNPRACTICEGET INVOLVEDSHOP ABOUTNEWS Search form Search Advanced Search LEARNPRACTICEGET INVOLVEDSHOP ABOUTNEWS Menu LEARNCAREER CENTERJOB SEARCHPATHWAYSRESIDENCIESCONTINUING EDUCATIONHOME STUDY CPELIVE ACTIVITIESTRAINING PROGRAMSAMBULATORY CARE REVIEW AND RECERTIFICATIONTECHNICIANSMY TRAININGPRACTICEMTM CENTRALIMPLEMENTING MTM IN YOUR PRACTICEADVANCING THE VALUE OF MTMMTM RESOURCE LIBRARYIMMUNIZATION CENTERAPhA IMMUNIZATION GUIDELINESADMINISTRATION TECHNIQUEASK THE EXPERTSINFECTIOUS DISEASECOMPOUNDINGFREQUENTLY ASKED QUESTIONSSPECIALTY PHARMACYTOPICS IN PRACTICEPATIENT OUTREACH TOOLSSAFETY NET PROVIDERSAPPOINTMENT BASED MODELGET INVOLVEDPARTICIPATEHOUSE OF DELEGATESAPhA-APPMAPhA-APRSAPhA-ASPNEW PRACTITIONER NETWORKELECTIONSANNUAL MEETING & EXPOSITIONJOINT FEDERAL PHARMACY SEMINARAWARDSJOIN APhAWHY JOIN APhA?RENEW YOUR MEMBERSHIPAPhA CORPORATE SUPPORTERSUSING YOUR APhA BENEFITSADVOCATEISSUESACTIONAPhA-PACPROVIDER STATUSENGAGE COMMUNITIESAMERICAN PHARMACISTS MONTHSHOPSHOP APhA PRODUCTSAPhA E-BOOKSFACULTY RESOURCESLEXICOMP PRODUCTSCORRECTIONS ABOUTWHO WE AREHISTORY OF APhAGOVERNANCE AND LEADERSHIPAPhA DEPARTMENT CONTACTSEXTERNAL SUPPORTEMPLOYMENTTHE PHARMACY PROFESSIONGETTING THE MOST FROM YOUR PHARMACISTNEWSPHARMACY TODAYABOUTDIGITAL READERCURRENT ISSUEPAST ISSUESINFORMATIONAL RESOURCESLETTERS TO THE EDITORADVERTISESUBSCRIBESTUDENT PHARMACISTDIGITAL READERCURRENT ISSUEPAST ISSUESADVERTISEAPhA DRUGINFOLINEJAPhAJPHARMSCICEO BLOGMEDIA RESOURCESAPhA TV NEWS PHARMACY TODAYABOUTDIGITAL READERCURRENT ISSUEPAST ISSUESINFORMATIONAL RESOURCESLETTERS TO THE EDITORADVERTISESUBSCRIBESTUDENT PHARMACISTDIGITAL READERCURRENT ISSUEPAST ISSUESADVERTISEAPhA DRUGINFOLINEJAPhAJPHARMSCICEO BLOGMEDIA RESOURCESAPhA TV Experience Select One That Best Describes you StudentStudent PractitionerPractitioner ScientistScientist Advertisement

Hospira issues a voluntary global recall of multiple lots of ketorolac tromethamine injection Share This Page
  February 12, 2015Hospira announced a voluntary recall of multiple lots of ketorolac tromethamine injection, USP after customer reports of particular matter in glass vials. The particulate was identified as calcium-ketorolac crystals.

Hospira announced a voluntary recall of multiple lots of ketorolac tromethamine injection, USP after customer reports of particular matter in glass vials. The particulate was identified as calcium-ketorolac crystals. The lots being recalled were distributed from February 2013 to December 2014 in the United States and from January 2014 to July 2014 in Singapore. Although Hospira has not received any reports related to the particulate in these lots, the company has launched an investigation into the issue.

FDA Alert (02/11/2015)

Ad Position: Bottom-Right http://www.fda.gov/Safety/Recalls/ucm433857.htm Advertisement

Related Content

block-views-related-content-block  Back to TopBack to Top LEARNCAREER CENTERCONTINUING EDUCATIONPRACTICEMTM CENTRALIMMUNIZATION CENTERINFECTIOUS DISEASECOMPOUNDINGSPECIALTY PHARMACYTOPICS IN PRACTICEAPPOINTMENT BASED MODELGET INVOLVEDPARTICIPATEJOIN APhAADVOCATEPROVIDER STATUSENGAGE COMMUNITIESAMERICAN PHARMACISTS MONTHSHOPSHOP APhA PRODUCTSAPhA E-BOOKSFACULTY RESOURCESLEXICOMP PRODUCTSCORRECTIONS MEMBER CENTERTHE APhA FOUNDATIONPHARMACY LIBRARYBUYERS GUIDE

American Pharmacists Association2215 Constitution Avenue NW, Washington, DC 20037? 2015 American Pharmacists Association All Rights Reserved.tel. 202.628.4410fax 202.783.2351SitemapPrivacy Policy Terms of Use View in Desktop ModeLogin/Register   PHARMACY TODAYABOUTDIGITAL READERCURRENT ISSUEPAST ISSUESINFORMATIONAL RESOURCESLETTERS TO THE EDITORADVERTISESUBSCRIBESTUDENT PHARMACISTDIGITAL READERCURRENT ISSUEPAST ISSUESADVERTISEAPhA DRUGINFOLINEJAPhAJPHARMSCICEO BLOGMEDIA RESOURCESAPhA TV Featured  Policy 101: Medically underserved communities   Olaparib: new drug for advanced ovarian cancer

 

CAREER CENTERJOB SEARCHPATHWAYSRESIDENCIESCONTINUING EDUCATIONHOME STUDY CPELIVE ACTIVITIESTRAINING PROGRAMSAMBULATORY CARE REVIEW AND RECERTIFICATIONTECHNICIANSMY TRAINING FeaturedOur profession's storytellers get the word out!


Pharmacist license revocation reversed

 

MTM CENTRALIMPLEMENTING MTM IN YOUR PRACTICEADVANCING THE VALUE OF MTMMTM RESOURCE LIBRARYIMMUNIZATION CENTERAPhA IMMUNIZATION GUIDELINESADMINISTRATION TECHNIQUEASK THE EXPERTSINFECTIOUS DISEASECOMPOUNDINGFREQUENTLY ASKED QUESTIONSSPECIALTY PHARMACYTOPICS IN PRACTICEPATIENT OUTREACH TOOLSSAFETY NET PROVIDERSAPPOINTMENT BASED MODEL FeaturedNew Mexican pharmacists create care transitions program
 


Choe enhances health care for Michigan patients PARTICIPATEHOUSE OF DELEGATESAPhA-APPMAPhA-APRSAPhA-ASPNEW PRACTITIONER NETWORKELECTIONSANNUAL MEETING & EXPOSITIONJOINT FEDERAL PHARMACY SEMINARAWARDSJOIN APhAWHY JOIN APhA?RENEW YOUR MEMBERSHIPAPhA CORPORATE SUPPORTERSUSING YOUR APhA BENEFITSADVOCATEISSUESACTIONAPhA-PACPROVIDER STATUSENGAGE COMMUNITIESAMERICAN PHARMACISTS MONTH Featured Give clear, explicit directions to patientsPharmacist Aldrich reduces readmissions, incorrect med usage in NM

 

SHOP APhA PRODUCTSAPhA E-BOOKSFACULTY RESOURCESLEXICOMP PRODUCTSCORRECTIONS Featured Pharmacy Technician Skills-Building Manual 

 

WHO WE AREHISTORY OF APhAGOVERNANCE AND LEADERSHIPAPhA DEPARTMENT CONTACTSEXTERNAL SUPPORTEMPLOYMENTTHE PHARMACY PROFESSIONGETTING THE MOST FROM YOUR PHARMACIST Featured  APhA2015: Let's advance as one!Today's Perspective: Remembering the basics

 


View the original article here

0 comments